Skip to main content
An official website of the United States government

nanoparticle formulation CPI-300

A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.
Synonym:nanoscale coordination polymer-based formulation CPI-300
NCP platform-based CPI-300
Code name:CPI 300
CPI-300
CPI300
Search NCI's Drug Dictionary